Additional Risk minimization materials to minimize potential risk associated with the use of medicines. The materials have been assessed and approved by the national competent authority in line with their Marketing Authorization.

Select your country
Austria
Denmark
Finland
France
Germany
Ireland
Italy
Portugal
Netherlands
Norway
Spain
Sweden
United Kingdom
Terms & Conditions
Privacy Policy
Samsung Bioepis
×

Contact Us

To report an adverse event or make a product complaint, or to request more information about Samsung Bioepis products, please email us at bioepis.mi@medinformation.co.uk.